These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 20086172)

  • 1. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
    Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
    Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
    Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
    Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo.
    Wei W; Chen ZJ; Zhang KS; Yang XL; Wu YM; Chen XH; Huang HB; Liu HL; Cai SH; Du J; Wang HS
    Cell Death Dis; 2014 Oct; 5(10):e1428. PubMed ID: 25275589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DHEA metabolite 7β-hydroxy-epiandrosterone exerts anti-estrogenic effects on breast cancer cell lines.
    Sandra N; Ester P; Marie-Agnès P; Robert M; Olivier H
    Steroids; 2012 Apr; 77(5):542-51. PubMed ID: 22342541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.
    Kang L; Zhang X; Xie Y; Tu Y; Wang D; Liu Z; Wang ZY
    Mol Endocrinol; 2010 Apr; 24(4):709-21. PubMed ID: 20197310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of G protein-coupled receptor 30 by thiodiphenol promotes proliferation of estrogen receptor α-positive breast cancer cells.
    Lei B; Peng W; Xu G; Wu M; Wen Y; Xu J; Yu Z; Wang Y
    Chemosphere; 2017 Feb; 169():204-211. PubMed ID: 27880919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.
    Girgert R; Emons G; Gründker C
    Breast Cancer Res Treat; 2012 Jul; 134(1):199-205. PubMed ID: 22290080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
    Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
    Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
    Maggiolini M; Vivacqua A; Fasanella G; Recchia AG; Sisci D; Pezzi V; Montanaro D; Musti AM; Picard D; Andò S
    J Biol Chem; 2004 Jun; 279(26):27008-16. PubMed ID: 15090535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cell line competence for studies of pharmacological GPR30 modulation.
    Sousa C; Ribeiro M; Rufino AT; Leitão AJ; Mendes AF
    J Recept Signal Transduct Res; 2017 Apr; 37(2):181-188. PubMed ID: 27401115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
    Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
    FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells.
    Peng J; Jordan VC
    Int J Oncol; 2010 Feb; 36(2):451-8. PubMed ID: 20043081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals.
    Gao F; Ma X; Ostmann AB; Das SK
    Endocrinology; 2011 Apr; 152(4):1434-47. PubMed ID: 21303939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells.
    Li Y; Jiang B; Wu X; Huang Q; Chen W; Zhu H; Qu X; Xie L; Ma X; Huang G
    Biochem Biophys Res Commun; 2018 Sep; 503(1):45-50. PubMed ID: 29792859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
    Albanito L; Sisci D; Aquila S; Brunelli E; Vivacqua A; Madeo A; Lappano R; Pandey DP; Picard D; Mauro L; Andò S; Maggiolini M
    Endocrinology; 2008 Aug; 149(8):3799-808. PubMed ID: 18467441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.
    Chan QK; Lam HM; Ng CF; Lee AY; Chan ES; Ng HK; Ho SM; Lau KM
    Cell Death Differ; 2010 Sep; 17(9):1511-23. PubMed ID: 20203690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.
    Marchese S; Silva E
    PLoS One; 2012; 7(10):e45767. PubMed ID: 23056216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.